The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.34BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue (TTM)
1.04BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Profit Margin
-6.08%
vs Medical Devices peers
Updated Oct 28, 2026
Beta
1.66x
vs all stocks
Updated Oct 28, 2026
52-Week Change
27.03%
vs all stocks
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Market Capitalization
1.34BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Enterprise Value
1.62BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward P/E
120.91x
vs Medical Devices peers
Updated Oct 28, 2026
Price to Sales (TTM)
1.28x
vs Medical Devices peers
Updated Oct 28, 2026
Price to Book (MRQ)
10.25x
vs Medical Devices peers
Updated Oct 28, 2026
Enterprise to Revenue
1.56x
vs Medical Devices peers
Updated Oct 28, 2026
Enterprise to EBITDA
-64.74x
vs Medical Devices peers
Updated Oct 28, 2026
Gross Margin
56.87%
vs Medical Devices peers
Updated Oct 28, 2026
Profit Margin
-6.08%
vs Medical Devices peers
Updated Oct 28, 2026
Operating Margin
-5.42%
vs Medical Devices peers
Updated Oct 28, 2026
Return on Assets (TTM)
-2.65%
vs Medical Devices peers
Updated Oct 28, 2026
Return on Equity (TTM)
-48.03%
vs Medical Devices peers
Updated Oct 28, 2026
Revenue (TTM)
1.04BUSD
vs all stocks (USD)
Updated Oct 28, 2026
Revenue per Share (TTM)
15.25USDUpdated Oct 28, 2026
Quarterly Revenue Growth
5.80%
vs Medical Devices peers
Updated Oct 28, 2026
Gross Profit (TTM)
583.32MUSD
vs all stocks (USD)
Updated Oct 28, 2026
EBITDA (TTM)
-25.03MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Net Income (TTM)
-63.31MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Operating Cash Flow (TTM)
-5.52MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Levered Free Cash Flow (TTM)
-43.95MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 28, 2026
Payout Ratio
0.00%
vs Medical Devices peers
Updated Oct 28, 2026
Revenue
1.01BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
468.72MUSDFY2025 · Dec 31, 2025
Gross Profit
546.01MUSDFY2025 · Dec 31, 2025
Operating Income
-167.31MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-200.27MUSDFY2025 · Dec 31, 2025
Income Tax Expense
4.44MUSDFY2025 · Dec 31, 2025
Net Income
-204.71MUSDFY2025 · Dec 31, 2025
EBIT
-194.22MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-156.61MUSDFY2025 · Dec 31, 2025
Research & Development
268.33MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
444.99MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
9.09MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
6.05MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-3.04USDFY2025 · Dec 31, 2025
EPS (Diluted)
-3.04USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
67.28MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
67.28MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-204.71MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-19.81MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-39.76MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
90.63MUSDFY2025 · Dec 31, 2025
Income Tax Paid
5.06MUSDFY2025 · Dec 31, 2025
Interest Paid
5.05MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-204.71MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
17.67MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
92.38MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
88.14MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-56.81MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
2.23MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
41.30MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-19.95MUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
-78.59MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-85.66MUSDFY2025 · Dec 31, 2025
Sale of Investments
257.07MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
151.46MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-40.76MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-40.76MUSDFY2025 · Dec 31, 2025
Shares Outstanding
69.54MSharesUpdated Oct 28, 2026
Float Shares
63.76MSharesUpdated Oct 28, 2026
Shares Short
15.09MSharesUpdated Oct 28, 2026
Short Ratio
6.27days
vs all stocks
Updated Oct 28, 2026
Short % of Shares Outstanding
29.04%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 21.69%.Updated Oct 28, 2026
% Held by Insiders
1.17%
vs all stocks
Updated Oct 28, 2026
% Held by Institutions
115.65%
vs all stocks
Updated Oct 28, 2026
Total Cash (MRQ)
456.00MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Cash per Share (MRQ)
6.55USDUpdated Oct 28, 2026
Total Debt (MRQ)
739.25MUSD
vs all stocks (USD)
Updated Oct 28, 2026
Total Debt to Equity (MRQ)
5.67x
vs Medical Devices peers
Updated Oct 28, 2026
Current Ratio (MRQ)
3.18x
vs Medical Devices peers
Updated Oct 28, 2026
Book Value per Share (MRQ)
1.88USDUpdated Oct 28, 2026
Total Assets
881.11MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
618.14MUSDFY2025 · Dec 31, 2025
Total Liabilities
725.94MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
262.97MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
483.22MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
242.72MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
90.63MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
202.03MUSDFY2025 · Dec 31, 2025
Accounts Receivable
165.49MUSDFY2025 · Dec 31, 2025
Inventory
128.77MUSDFY2025 · Dec 31, 2025
Accounts Payable
47.07MUSDFY2025 · Dec 31, 2025
Short-term Debt
19.47MUSDFY2025 · Dec 31, 2025
Deferred Revenue
9.53MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
75.24MUSDFY2025 · Dec 31, 2025
Long-term Debt
425.00MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
49.74MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
68.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-1.25BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
155.17MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
12.26USDUpdated Oct 28, 2026
52-Week High
29.65USDUpdated Oct 28, 2026
52-Week Change
27.03%
vs all stocks
Updated Oct 28, 2026
Beta
1.66x
vs all stocks
Updated Oct 28, 2026
50-Day MA
18.25USDUpdated Oct 28, 2026
200-Day MA
18.95USDUpdated Oct 28, 2026
Avg 10-Day Volume
2.31MSharesUpdated Oct 28, 2026
Avg 30-Day Volume
2.31MSharesUpdated Oct 28, 2026
Diluted EPS (TTM)
-0.9100USDUpdated Oct 28, 2026
Other Income / Expense
-34.15MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 5.67×, higher than 95% of its Medical Devices peers (median 0.16×)Significant